POSTER SESSION IV
Tuesday, March 20, 2012 — 1:00 PM - 4:30 PM
CC Exhibit Hall B3 & C
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
PULMONARY PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
292
mTOR Expression in Pulmonary Neuroendocrine Tumors
(2048)
PA Toro, C Alenda, G Peiro, A Teruel, E Rojas, I Aranda - Hospital General de Alicante, Alicante, Comunidad Valenciana, Spain
Histone 1.5 (H1.5) Staining Directly Correlates with High Grade in Pulmonary Neuroendocrine Tumors
(2000)
H-BM Ko, JF Hechtman, Y Kinoshita, DE Burstein, MB Beasley - Mount Sinai School of Medicine, New York
PLZF Immunstaining Inversely Correlates with Aggressiveness in Pulmonary Neuroendocrine Tumors
(1991)
JF Hechtman, Y Kinoshita, MB Beasley, DE Burstein - Mount Sinai School of Medicine, New York, NY
PAX2, PAX5, and PAX8 Expression in Pulmonary Neuroendocrine Tumors
(1999)
S Kirby, W Frankel, W Marsh, F Junya, J Jen, T Franks, W Travis, K Shilo - The Ohio State University Medical Center, Columbus, OH; Toyama University Hospital, Toyoma, Japan; Mayo Clinic, Rochester, MN; JPC, Silver Spring, MD; Memorial Sloan- Kettering Cancer Center, New York, NY
Testing for 29 EGFR TKI Sensitivity and Resistance Mutations in Lung Cancer Using EGFR RGQ PCR Kit
(1976)
M Cankovic, L Whiteley, DA Chitale - Henry Ford Hospital, Detroit, MI
Highly Sensitive Real-Time PCR for the Detection of EGFR Mutations in Lung Adenocarcinoma. Is It Worth It?
(2034)
N Rodon, R Roman, M Verdu, B Garcia, M Pujol, X Puig - BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; Histopat Laboratoris, Barcelona, Spain
Absence of TTF-1 Immunoreactivity Can Predict EGFR Wild- Type in Non-Small Cell Lung Cancer (NSCLC)
(1974)
I Bosdet, SS Young, RH Ali, BK McNeil, C Wong, K Garbutt, A Karsan, DN Ionescu - BC Cancer Agency, Vancouver, BC, Canada
Establishing Quantitative Parameters in the Detection of Somatic Mutations of the Epidermal Growth Factor Receptor Gene in Cytology Samples of Non-Small Cell Lung Carcinomas
(1975)
E Brega, G Chong, V Cohen, J Agulnik, G Kasymjanova, M Palayew, B Xu, D Small, G Batist, A Spatz, G Brandao - Jewish General Hospital/McGill University, Montreal, QC, Canada
Cytology Samples Are Comparable to Histological Samples for EGFR Mutation Testing in Non-Small Cell Lung Cancer (NSCLC)
(1973)
I Bosdet, RH Ali, S Young, A Karsan, DN Ionescu - BC Cancer Agency, Vancouver, BC, Canada
Molecular Testing for Lung Adenocarcinoma: Concordance between Cytology and Histology
(1993)
JJ Heymann, WA Bulman, RA Maxfield, CA Powell, B Halmos, M Stoopler, J Sonett, NT Beaubier, AM Babiac, AC Borczuk, MM Mansukhani, S Anjali - Columbia University Medical Center, New York, NY
Detection of EGFR Mutations in Lung Adenocarcinoma by Immunohistochemistry Using Mutant Specific Antibodies: Are We There Yet?
(1961)
K Arora, W Zhang, J Fukuoka, H Kitano, J Jagirdar - University of Texas Health Science Centre, San Antonio, TX; University of Toyama, Toyama, Japan; National Institutes of Health, Bethesda, MD
The Performance of an L858R Mutation Specific EGFR Antibody in Non-Small Cell Lung Cancer Specimens
(2004)
A Kyshtoobayeva, KJ Bloom - Clarient, A GE Healthcare Company, Aliso Viejo, CA
The Performance of an E746-A750del Mutation Specific EGFR Antibody in Non-Small Cell Lung Cancer Specimens
(2003)
A Kyshtoobayeva, KJ Bloom - Clarient, A GE Healthcare Company, Aliso Viejo, CA
EGFR Mutation Rates in 18246 Consecutive Non-Small Cell Lung Cancer Samples
(1969)
KJ Bloom, P Choppa - Clarient, A GE Healthcare Company, Aliso Viejo, CA
Epidermal Growth Factor Receptor Copy Number Variations, but Not EGFR or KRAS Mutations, Are Frequent in Lung Squamous Cell Carcinomas
(2035)
R Roman, N Rodon, M Verdu, B Garcia, M Pujol, M Calvo, X Puig - BIOPAT.Biopatologia Molecular, SL, Grup Assistencia, Barcelona, Spain; Hospital de Barcelona, SCIAS, Grup Assistencia, Barcelona, Spain; Histopat Laboratoris, Barcelona, Spain; Universitat de Barcelona, Statistics Department, Barcelona, Spain
Loss of PTEN Expression and Gene Copy Number in Non Small Cell Lung Cancer
(2008)
C Leduc, N Yanagawa, M Saieg, M Yoshimoto, T John, J Sykes, M Pintillie, G da Cunha Santos, J Squire, M-S Tsao - Queen´s University, Kingston, Canada; University Health Network, Ontario Cancer Institute/Princess Margaret Hospital, Toronto, Canada; Yamagata Prefectural Central Hospital, Yamagata, Japan
Ki-67 Is a Strong Prognostic Marker for Non Small Cell Lung Cancer When Tissue Heterogeneity Is Considered
(1982)
J Fukuoka, T Hori - Toyama University Hospital, Toyama, Japan
Thyroid Transcription Factor-1 Expression Correlates with Predominant Histologic Subtypes and Recurrence in Stage I Lung Adenocarcinoma Patients
(1996)
K Kadota, J-i Nitadori, K Suzuki, CS Sima, A Yoshizawa, VW Rusch, WD Travis, PS Adusumilli - Memorial Sloan-Kettering Cancer Center, New York
Identification of Protein Signature in the Bronchoalveolar Lavage (BAL) Specimen from Lung Adenocarcinoma by Quantitative Proteomics
(2011)
Q Li, Y Li, F Askin, E Gabrielson, H Zhang - The Johns Hopkins Medical Institutions and Bayview Medical Center, Baltimore, MD
Mucin5B (MUC5B) Expression Correlates with High Stage in Lung Adenocarcinoma by Quantitative Proteomics and Immunohistochemistry
(2010)
GH Lewis, Y Li, F Askin, E Gabrielson, H Zhang, QK Li - The Johns Hopkins Medical Institutions, Baltimore, MD
Expression of Biomarkers of Tumor Cell Plasticity in Lung Adenocarcinoma Isotypes
(2038)
O Rouhi, M Pool, LD Arvanitis, KA Kaiser, D Escarzaga, E Hadziahmetovic, M Liptay, B Mahon, JA Borgia - Rush University, Chicago, IL
Napsin A: Utility in Identifying Primary Mucinous Lung Adenocarcinomas Versus Mucinous Metastasis
(1960)
DE Amaro, GY Lin - UC San Diego Health Care System, San Diego
Comparison of Napsin A Expression in Tumors with Polyclonal and Monoclonal Antibodies
(2060)
S Zhu, J Shi, K Zhang, H Liu, M Wilkerson, F Lin - Geisinger Medical Center, Danville, PA
PAX8 Is Useful in Discriminating Metastatic Endometrioid Carcinoma with Infrequent TTF-1 and Napsin A Positivity in the Lung
(2056)
J Ye, J Fiscella, S Honnons, LA McMahon, Q Yang, F Li, H Xu - University of Rochester Medical Center, Rochester
Identification of an Effective Immunohistochemical Panel in Distinction of Breast Carcinoma from Lung Adenocarcinoma
(2012)
F Lin, S Zhu, H Deng, H Liu - Geisinger Medical Center, Danville, PA
button next to any title to add to Itinerary Planner...
Add
